|
IRF2BP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
1.381950E-04 |
| Normal-vs-Stage3 |
2.49289999999514E-05 |
| Normal-vs-Stage4 |
5.763500E-03 |
| Stage1-vs-Stage2 |
1.167980E-01 |
| Stage1-vs-Stage3 |
1.191900E-04 |
| Stage1-vs-Stage4 |
1.62380000001683E-07 |
| Stage2-vs-Stage3 |
2.333400E-01 |
| Stage2-vs-Stage4 |
5.154000E-02 |
| Stage3-vs-Stage4 |
2.522200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62547753035369E-12 |
| Normal-vs-AfricanAmerican |
6.36629999999361E-05 |
| Normal-vs-Asian |
7.516400E-02 |
| Caucasian-vs-AfricanAmerican |
8.754000E-01 |
| Caucasian-vs-Asian |
6.213400E-01 |
| AfricanAmerican-vs-Asian |
6.032400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.94422256072357E-12 |
| Normal-vs-Female |
1.32893696047631E-13 |
| Male-vs-Female |
2.272400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.813700E-02 |
| Normal-vs-Age(41-60Yrs) |
6.99440505513849E-15 |
| Normal-vs-Age(61-80Yrs) |
8.77575789814955E-12 |
| Normal-vs-Age(81-100Yrs) |
3.832400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.543400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.291400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.802200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.597500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.734000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.154000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.231140E-04 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
5.34089994452813E-09 |
| Normal-vs-Grade 4 |
2.186800E-01 |
| Grade 1-vs-Grade 2 |
1.014400E-02 |
| Grade 1-vs-Grade 3 |
1.52111999999205E-05 |
| Grade 1-vs-Grade 4 |
2.010400E-04 |
| Grade 2-vs-Grade 3 |
1.93954999999635E-05 |
| Grade 2-vs-Grade 4 |
7.23965332127818E-12 |
| Grade 3-vs-Grade 4 |
3.764700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
4.259400E-03 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.07750039393773E-10 |
| Normal-vs-N1 |
9.686800E-01 |
| N0-vs-N1 |
1.083160E-03 |
|
|
